Searching for Mounjaro via MediExpress? Here's what to consider first

What MediExpress is, and what that means for your Mounjaro search

MediExpress is a UK online pharmacy that appears in search results for a range of prescription medicines, including Mounjaro. If you found it while looking for tirzepatide, you were doing sensible comparison shopping. The question worth asking about any provider, though, isn't whether they come up in Google, it's whether they hold a valid GPhC pharmacy registration, conduct a genuine clinical assessment before dispensing, and source medicines through the licensed UK supply chain.

You can run that check on any online pharmacy in roughly 30 seconds: visit the GPhC's pharmacy register, enter the provider's name or registration number, and confirm the listing is active. If a pharmacy isn't there, walk away. It's a small step that carries a lot of weight.

For context, Mounjaro as a medicine is a Black Triangle (▼) product under additional MHRA monitoring, which means any pharmacy dispensing it is held to close regulatory scrutiny. A registration on the GPhC register is the minimum; the clinical process behind each prescription matters just as much.

How the prescribing process should work, regardless of which pharmacy you use

UK law requires that Mounjaro is prescribed following an individual clinical assessment. That isn't a formality: a prescriber needs to weigh up your BMI, weight-related health conditions, current medicines, and medical history before issuing a prescription. At nume, every consultation is personally reviewed by a GPhC-registered Independent Prescriber the same day, a real clinician reads your answers, not software.

The assessment also covers medicines that interact with tirzepatide. If you take antihypertensives, for instance, there are practical points your prescriber needs to factor in; the interaction between Mounjaro and blood pressure medicines is a common topic in these consultations. It's the kind of thing a tick-box online form can't reliably pick up on its own.

Treatment starts at the 2.5 mg dose, a tolerability level designed to let your body adjust before the dose is increased. The NHS medicines page for tirzepatide gives a clear overview of what to expect in the early weeks, including common side effects like nausea, indigestion, and fatigue, which tend to settle as your system adapts.

Cost and what it should include, a word on comparing providers

Price is the lens many people use when comparing services, which is understandable. Mounjaro is not cheap under any legitimate provider: Eli Lilly raised its UK list price significantly from September 2025, and private market prices have moved accordingly, typically ranging from around £149 to £375 per month depending on dose and provider. You can read more about the market picture on our Mounjaro price comparison page.

What those headline figures often exclude is worth scrutinising: some providers charge separately for the consultation, the prescription, or delivery. Some have no ongoing clinical oversight once the first pen is sent. For a prescription medicine, the cheapest listing answers the wrong question. The right test is what the price includes (clinical review, aftercare, genuine supply chain) and whether the pharmacy behind it is verifiably registered.

At nume, one transparent price covers the consultation, prescription, next-working-day DPD delivery, and priority aftercare seven days a week. There are no subscriptions and no hidden charges. If you want to understand more about how Mounjaro medi services are structured and what they typically include, that page sets it out clearly. The full picture on tirzepatide covers how the medicine works, what the evidence shows, and what private treatment involves in practice.

If Mounjaro is clinically suitable for you, what comes next

Mounjaro is licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. BMI alone doesn't decide anything, a prescriber looks at the full picture, including any contraindications. Pregnancy, breastfeeding, and trying to conceive are all situations where Mounjaro is not recommended; nor is it licensed for under-18s.

The SURMOUNT-1 trial (2,539 adults, 72 weeks) found average body-weight reductions of around 20–21% at the 15 mg dose, reported in the New England Journal of Medicine. Those results come with lifestyle changes (reduced calorie intake and increased activity) which are part of the licensed indication. If you want a closer look at how the Mounjaro medical evidence and prescribing criteria translate into practice, that page walks through the clinical detail. No medicine does this work alone.

If you're ready to find out whether Mounjaro is right for you, our prescribers are the right starting point. You can start your free consultation and receive a same-day clinical review, with treatment dispatched the same day if approved and delivered free the next working day.